跳至主要内容
临床试验/NCT00522509
NCT00522509Unknown不适用

Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases

IRCCS San Raffaele1 个研究点 分布在 1 个国家开始时间: 1995年12月最近更新:
适应症
相关药物

试验速览

阶段
不适用
试验地点
1

研究概览

简要总结

To assess the feasibility and results of liver resection after preoperative hepatic artery infusion (HAI) chemotherapy with FUDR.

详细描述

Between 1995 and 2004, 239 patients with isolated colorectal liver metastases received HAI chemotherapy with neoadjuvant intent. Fifty of these patients underwent subsequent curative liver resection (HAI group).

Postoperative morbidity, liver function tests, and long term outcomes were evaluated. Adverse events related to HAI chemotherapy were also evaluated.

研究设计

研究类型
Observational
观察模型
Defined Population
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Unresectable liver metastases
  • Potentially resectable liver metastases

排除标准

  • Extrahepatic disease

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Preoperative Hepatic Arterial Infusion Chemotherapy | 临床试验